You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/31951
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPerry, J. C.-
dc.contributor.authorDa Cunha, C.-
dc.contributor.authorAnselmo-Franci, J.-
dc.contributor.authorAndreatini, R.-
dc.contributor.authorMiyoshi, E.-
dc.contributor.authorTufik, S.-
dc.contributor.authorVital, MABF-
dc.date.accessioned2014-05-20T15:20:43Z-
dc.date.accessioned2016-10-25T17:53:53Z-
dc.date.available2014-05-20T15:20:43Z-
dc.date.available2016-10-25T17:53:53Z-
dc.date.issued2004-01-26-
dc.identifierhttp://dx.doi.org/10.1016/j.ejphar.2003.11.029-
dc.identifier.citationEuropean Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 484, n. 2-3, p. 225-233, 2004.-
dc.identifier.issn0014-2999-
dc.identifier.urihttp://hdl.handle.net/11449/31951-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/31951-
dc.description.abstractThe present study investigated the effects of intranigral MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) infusion on rats treated with phosphatidylserine and evaluated in two memory tasks and on striatal dopamine levels. The results indicated that MPTP produced a significant decrease in the avoidance number in comparison to sham-operated and non-operated rats submitted to a two-way avoidance task. MPTP-lesioned rats exhibited an increase in the latencies to find the platform in cued version of the water maze in comparison to sham-operated and non-operated animals. The tested toxin reduced striatal dopamine levels in comparison to sham-operated and non-operated groups. A final surprising result was that phosphatidylserine was unable to reverse the cognitive deficits produced by MPTP or the reduction of striatal dopamine levels. In conclusion, the data suggest that MPTP is a good model to study the early impairment associated with Parkinson's disease and phosphatidylserine did not improve the memory impairment induced by MPTP. (C) 2003 Elsevier B.V. All rights reserved.en
dc.format.extent225-233-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.sourceWeb of Science-
dc.subjectphosphatidylserinept
dc.subjectMPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)pt
dc.subjectmemorypt
dc.subject(Rat)pt
dc.subjectParkinson's diseasept
dc.subjectdopaminept
dc.titleBehavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of ratsen
dc.typeoutro-
dc.contributor.institutionUniversidade Federal do Paraná (UFPR)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)-
dc.description.affiliationUniversidade Federal do Paraná (UFPF), Dept Farmacol, Setor Ciências Biol, BR-81531990 Curitiba, Parana, Brazil-
dc.description.affiliationState Univ São Paulo, Fac Odontol, Dept Physiol, São Paulo, Brazil-
dc.description.affiliationUniv Fed São Paulo, Dept Psychobiol, São Paulo, Brazil-
dc.description.affiliationUnespState Univ São Paulo, Fac Odontol, Dept Physiol, São Paulo, Brazil-
dc.identifier.doi10.1016/j.ejphar.2003.11.029-
dc.identifier.wosWOS:000188610800013-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofEuropean Journal of Pharmacology-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
Show simple item record Show full item record   View Statistics
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.